CN1717229A - 组合物及其治疗神经病性感觉丧失的用途 - Google Patents

组合物及其治疗神经病性感觉丧失的用途 Download PDF

Info

Publication number
CN1717229A
CN1717229A CNA2003801041719A CN200380104171A CN1717229A CN 1717229 A CN1717229 A CN 1717229A CN A2003801041719 A CNA2003801041719 A CN A2003801041719A CN 200380104171 A CN200380104171 A CN 200380104171A CN 1717229 A CN1717229 A CN 1717229A
Authority
CN
China
Prior art keywords
lidocaine
nsp
anesthetic
neuropathic
site
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2003801041719A
Other languages
English (en)
Chinese (zh)
Inventor
B·S·盖勒
A·R·加梅托尼
R·D·德沃金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endo Pharmaceuticals Inc
Original Assignee
Endo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Pharmaceuticals Inc filed Critical Endo Pharmaceuticals Inc
Publication of CN1717229A publication Critical patent/CN1717229A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA2003801041719A 2002-11-26 2003-11-25 组合物及其治疗神经病性感觉丧失的用途 Pending CN1717229A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42920802P 2002-11-26 2002-11-26
US60/429,208 2002-11-26

Publications (1)

Publication Number Publication Date
CN1717229A true CN1717229A (zh) 2006-01-04

Family

ID=32393523

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2003801041719A Pending CN1717229A (zh) 2002-11-26 2003-11-25 组合物及其治疗神经病性感觉丧失的用途

Country Status (9)

Country Link
EP (1) EP1565173B1 (enExample)
JP (1) JP2006509766A (enExample)
CN (1) CN1717229A (enExample)
AT (1) ATE420633T1 (enExample)
AU (1) AU2003298710B2 (enExample)
CA (1) CA2507217C (enExample)
DE (1) DE60325885D1 (enExample)
ES (1) ES2319764T3 (enExample)
WO (1) WO2004047819A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
US7592458B2 (en) 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
CA2732784C (en) * 2008-08-13 2018-09-18 Neuroquest Inc. Compositions comprising terpene compounds for treating negative sensory phenomena
CA2738524C (en) 2008-10-02 2013-11-26 Mylan Inc. Method for making a multilayer adhesive laminate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5993018A (ja) * 1982-11-18 1984-05-29 Sumitomo Chem Co Ltd 顔面錯感覚症治療薬
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents

Also Published As

Publication number Publication date
ATE420633T1 (de) 2009-01-15
DE60325885D1 (de) 2009-03-05
CA2507217A1 (en) 2004-06-10
AU2003298710B2 (en) 2008-02-07
WO2004047819A2 (en) 2004-06-10
EP1565173A2 (en) 2005-08-24
WO2004047819A3 (en) 2004-07-29
EP1565173B1 (en) 2009-01-14
CA2507217C (en) 2012-08-28
ES2319764T3 (es) 2009-05-12
JP2006509766A (ja) 2006-03-23
AU2003298710A1 (en) 2004-06-18

Similar Documents

Publication Publication Date Title
JP5148271B2 (ja) 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物
CA2070685C (en) Method for treating painful, inflammatory or allergic disorders
CA2569072A1 (en) Preparation for localized delivery of therapeutic agent
Altman et al. Local anesthetics
Rodriguez-Navarro et al. Potentiation of local anesthetic activity of neosaxitoxin with bupivacaine or epinephrine: development of a long-acting pain blocker
CA2893768C (en) Topical preparation for pain relief
US11458113B2 (en) Topical formulations and treatments
CA2507217C (en) Compositions and methods for treating neuropathic sensory loss
US20050112183A1 (en) Compositions and methods for treating neuropathic sensory loss
KR20050085736A (ko) 에스테르 조합 국소마취제
US4312865A (en) Medication having penetration through cutaneous surfaces into articular and muscular areas
AU738165B2 (en) Useful formulations of acid addition salt drugs
Zimmet Hyaluronidase in the prevention of sclerotherapy‐induced extravasation necrosis: a dose‐response study
CA2230648A1 (en) Formulations of haloalkylamines and local anaesthetics and methods for the treatment of reflex sympathetic dystrophy (rsd)
Malik et al. Intravenous regional phenoxybenzamine in the treatment of reflex sympathetic dystrophy
CN113398101B (zh) 一种复方利多卡因凝胶贴剂
Amjad et al. Acetonide with lignocaine compared with lignocaine alone in the treatment of post herpetic neuralgia
Agarwal et al. Comparative evaluation of Myolaxin and EM LA cream for attenuation of venous cannulation pain: A prospective, randomised, double blind study
WO2002067896A1 (en) Ibutilide and methanesulfonamide for local anesthetics
US20060127318A1 (en) Composition and method of a topical treatment of neurodermatitis
Kramer et al. Overview of Local Anesthesia
Hong et al. Pretreatmet with 5% lidocaine patch reduces cannula-induced and propofol-induced pain: a randomized, double-blind, placebo-controlled study
Maimon et al. Lidocaine v bupivacaine in facial plastic surgery: a clinical trial
Joad et al. INTRAVENOUS LIGNOCAINE INFUSION FOR NEUROPATHIC PAIN IN CANCER PATIENTS–A PRELIMINARY STUDY
Riad Lidocaine transdermal

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060104